This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Annemette Thougaard: Innovator in Cancer Treatment
Introduction
Annemette Thougaard is a notable inventor based in Denmark, recognized for her contributions to cancer treatment methodologies. Her innovative approach focuses on the combination of topoisomerase-II inhibitors and radiation therapy, aiming to enhance the effectiveness of cancer treatments.
Latest Patents
Annemette Thougaard holds a patent titled "Cancer Treatment With Topoisomerase-Ii Inhibitor, A Bis-Dioxypiperazine And Radiation." This invention relates to a method of treating tumor cells by administering an effective amount of a topoisomerase-II poison, such as etoposide, in conjunction with a bis-dioxypiperazine, like dexrazoxane, while also applying radiation therapy. Despite her significant work, she currently has 0 patents registered.
Career Highlights
Annemette Thougaard has made substantial strides in her career, particularly in the field of oncology. Her research and development efforts have contributed to advancing treatment options for patients suffering from various forms of cancer. She is associated with Biocodex, a company that focuses on innovative pharmaceutical solutions.
Collaborations
Due to space constraints, the details of her collaborations will not be included.
Conclusion
Annemette Thougaard's work in cancer treatment exemplifies the impact of innovative thinking in medicine. Her dedication to improving therapeutic strategies continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile